These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37704415)

  • 21. A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes.
    Alish CJ; Garvey WT; Maki KC; Sacks GS; Hustead DS; Hegazi RA; Mustad VA
    Diabetes Technol Ther; 2010 Jun; 12(6):419-25. PubMed ID: 20470226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study on the effect of enteral feeding on blood glucose.
    Campbell J; McDowell JR
    Br J Nurs; 2007 Mar 22-Apr 11; 16(6):344-9. PubMed ID: 17505388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensive Versus Conventional Glycemic Control in Patients with Diabetes During Enteral Nutrition After Gastrectomy.
    Yuan J; Liu T; Zhang X; Si Y; Ye Y; Zhao C; Wang Q; Shen X
    J Gastrointest Surg; 2015 Aug; 19(8):1553-8. PubMed ID: 26084869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group.
    Roberts A; James J; Dhatariya K;
    Diabet Med; 2018 Aug; 35(8):1011-1017. PubMed ID: 30152586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-management of diabetes in hospital: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group.
    Flanagan D; Dhatariya K; Kilvert A;
    Diabet Med; 2018 Aug; 35(8):992-996. PubMed ID: 29923215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
    Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
    Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Premixed vs basal-bolus insulin regimen in Type 2 diabetes: comparison of clinical outcomes from randomized controlled trials and real-world data.
    Anyanwagu U; Mamza J; Gordon J; Donnelly R; Idris I
    Diabet Med; 2017 Dec; 34(12):1728-1736. PubMed ID: 28945928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of low-carbohydrate/high-monounsaturated fatty acid liquid diets on diurnal glucose variability and insulin dose in type 2 diabetes patients on tube feeding who require insulin therapy.
    Mori Y; Ohta T; Yokoyama J; Utsunomiya K
    Diabetes Technol Ther; 2013 Sep; 15(9):762-7. PubMed ID: 23931715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Royal College of Psychiatrists Liaison Faculty & Joint British Diabetes Societies (JBDS): guidelines for the management of diabetes in adults and children with psychiatric disorders in inpatient settings.
    Price HC; Ismail K;
    Diabet Med; 2018 Aug; 35(8):997-1004. PubMed ID: 30152583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Clar C; Marien M; Richter B; Philip S
    Health Technol Assess; 2010 Jul; 14(36):1-248. PubMed ID: 20646668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium-glucose cotransporter inhibitors with insulin for treatment of type 1 diabetes (Updated October 2020).
    Dashora U; Patel DC; Gregory R; Winocour P; Dhatariya K; Rowles S; Macklin A; Rayman G; Nagi D;
    Diabet Med; 2021 Feb; 38(2):e14458. PubMed ID: 33179277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of enteral nutritional suspension (diabetes) (TPF-DM) on blood glucose, serum insulin and lipids in patients with type 2 diabetes].
    Li YX; Pan SH; Zeng JB; Yu K; Sun Q; Liu QY; Qin W; Zhang Q; Pan QR; Yu JC; Xu T; Han SM; Wang H
    Zhonghua Nei Ke Za Zhi; 2007 Mar; 46(3):193-6. PubMed ID: 17547798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy.
    Hsia E; Seggelke SA; Gibbs J; Rasouli N; Draznin B
    Nutr Clin Pract; 2011 Dec; 26(6):714-7. PubMed ID: 22205560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes.
    Ashwell SG; Amiel SA; Bilous RW; Dashora U; Heller SR; Hepburn DA; Shutler SD; Stephens JW; Home PD
    Diabet Med; 2006 Mar; 23(3):285-92. PubMed ID: 16492212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A national survey of in-patient diabetes services in the United Kingdom.
    Sampson MJ; Brennan C; Dhatariya K; Jones C; Walden E
    Diabet Med; 2007 Jun; 24(6):643-9. PubMed ID: 17403116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Diabetes-Specific Enteral Nutrition Formula on Cardiometabolic Parameters in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    Ojo O; Weldon SM; Thompson T; Crockett R; Wang XH
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31443185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basal Insulin Reduces Glucose Variability and Hypoglycaemia Compared to Premixed Insulin in Type 2 Diabetes Patients: A Study Based on Continuous Glucose Monitoring Systems.
    Wang H; Zhou Y; Wang Y; Cai T; Hu Y; Jing T; Ding B; Su X; Li H; Ma J
    Front Endocrinol (Lausanne); 2022; 13():791439. PubMed ID: 35574003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial.
    Pasquel FJ; Gianchandani R; Rubin DJ; Dungan KM; Anzola I; Gomez PC; Peng L; Hodish I; Bodnar T; Wesorick D; Balakrishnan V; Osei K; Umpierrez GE
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):125-133. PubMed ID: 27964837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.